STU3 Candidate

This page is part of the FHIR Specification (v1.8.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0311.xml

Raw XML (canonical form)

Dosage with a Pre-Condition - Alprazolam (id = "medadmin0311")

<MedicationAdministration xmlns="http://hl7.org/fhir"> 
  <id value="medadmin0311"/>
  <text><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: medadmin0311</p><p><b>contained</b>: </p><p><b>status</b>: completed</p><p><b>medication</b>: id: med0304; Alprazolam 0.25mg Oral Tablet <span>(Details : {RxNorm code '308047' = '308047', given as 'Alprazolam 0.25mg Oral Tablet'})</span></p><p><b>patient</b>: <a>Donald Duck</a></p><p><b>effective</b>: 15/01/2015 10:03:00 PM --&gt; 16/01/2015 2:03:00 AM</p><p><b>performer</b>: <a>Patrick Pump</a></p><p><b>prescription</b>: <a>MedicationRequest/medrx0305</a></p><p><b>reasonGiven</b>: Dysmenorrhea <span>(Details : {SNOMED CT code '266599000' = 'Dysmenorrhea', given as 'Dysmenorrhea'})</span></p><h3>Dosages</h3><table><tr><td>-</td><td><b>Text</b></td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015.  Do not exceed more
             than 4mg per day</td><td>Oral Route <span>(Details : {SNOMED CT code '26643006' = 'Oral route (qualifier value)', given as 'Oral
               Route'})</span></td><td>1 TAB<span> (Details: http://hl7.org/fhir/ValueSet/v3-orderableDrugForm code TAB = 'TAB')</span></td></tr></table></div></text><contained>
    <Medication>
      <id value="med0304"/>
      <code>
        <coding>
          <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
          <code value="308047"/>
          <display value="Alprazolam 0.25mg Oral Tablet"/>
        </coding>
      </code>
    </Medication>
  </contained>
  <status value="completed"/>
  <medicationReference>
    <reference value="#med0304"/>
  </medicationReference>
 <patient>
   <reference value="Patient/pat1"/>
   <display value="Donald Duck"/> 
  </patient>
 <effectivePeriod>
  <start value="2015-01-15T22:03:00+01:00"/>
   <end value="2015-01-16T02:03:00+01:00"/>
</effectivePeriod>
 <performer>
    <reference value="Practitioner/f007"/>
    <display value="Patrick Pump"/>
 </performer>
  <prescription>
    <reference value="MedicationRequest/medrx0305"/>
  </prescription>
  <reasonGiven>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="266599000"/>
      <display value="Dysmenorrhea"/>
    </coding>
  </reasonGiven>
  <dosage>
    <text value="0.25mg PO every 6-12 hours as needed for menses from Jan 15-20, 2015.  Do not exceed more
     than 4mg per day"/>
    <route>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="26643006"/>
        <display value="Oral Route"/>
      </coding>
    </route>
    <dose>
      <value value="1"/>
      <unit value="TAB"/>
      <system value="http://hl7.org/fhir/ValueSet/v3-orderableDrugForm"/>
      <code value="TAB"/> 
    </dose>
  </dosage>
</MedicationAdministration>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.